128 related articles for article (PubMed ID: 19138992)
1. The dietary flavones apigenin and luteolin impair smooth muscle cell migration and VEGF expression through inhibition of PDGFR-beta phosphorylation.
Lamy S; Bédard V; Labbé D; Sartelet H; Barthomeuf C; Gingras D; Béliveau R
Cancer Prev Res (Phila); 2008 Nov; 1(6):452-9. PubMed ID: 19138992
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation.
Sparwel J; Vantler M; Caglayan E; Kappert K; Fries JW; Dietrich H; Böhm M; Erdmann E; Rosenkranz S
Cardiovasc Res; 2009 Mar; 81(4):758-70. PubMed ID: 19074160
[TBL] [Abstract][Full Text] [Related]
3. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling.
Lamy S; Beaulieu E; Labbé D; Bédard V; Moghrabi A; Barrette S; Gingras D; Béliveau R
Carcinogenesis; 2008 May; 29(5):1033-41. PubMed ID: 18339683
[TBL] [Abstract][Full Text] [Related]
4. Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavonoids of apigenin and luteolin as acting compounds.
Kim DI; Lee TK; Lim IS; Kim H; Lee YC; Kim CH
Toxicol Appl Pharmacol; 2005 Jun; 205(3):213-24. PubMed ID: 15922007
[TBL] [Abstract][Full Text] [Related]
5. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor stimulates a novel calcium-signaling pathway in vascular smooth muscle cells.
Chandra A; Angle N
Surgery; 2005 Oct; 138(4):780-7. PubMed ID: 16269309
[TBL] [Abstract][Full Text] [Related]
7. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
8. Fingolimod inhibits PDGF-B-induced migration of vascular smooth muscle cell by down-regulating the S1PR1/S1PR3 pathway.
Mousseau Y; Mollard S; Richard L; Nizou A; Faucher-Durand K; Cook-Moreau J; Qiu H; Baaj Y; Funalot B; Fourcade L; Sturtz FG
Biochimie; 2012 Dec; 94(12):2523-31. PubMed ID: 22828274
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
10. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling.
Kano MR; Morishita Y; Iwata C; Iwasaka S; Watabe T; Ouchi Y; Miyazono K; Miyazawa K
J Cell Sci; 2005 Aug; 118(Pt 16):3759-68. PubMed ID: 16105884
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells.
Getachew R; Ballinger ML; Burch ML; Little PJ; Osman N
Eur J Pharmacol; 2010 Jan; 626(2-3):186-92. PubMed ID: 19818754
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function.
Liu Y; Dolence J; Ren J; Rao M; Sreejayan N
J Cardiovasc Pharmacol; 2008 Nov; 52(5):422-9. PubMed ID: 19033821
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound.
Labrecque L; Lamy S; Chapus A; Mihoubi S; Durocher Y; Cass B; Bojanowski MW; Gingras D; Béliveau R
Carcinogenesis; 2005 Apr; 26(4):821-6. PubMed ID: 15661805
[TBL] [Abstract][Full Text] [Related]
14. Luteolin inhibited hydrogen peroxide-induced vascular smooth muscle cells proliferation and migration by suppressing the Src and Akt signalling pathways.
Lang Y; Chen D; Li D; Zhu M; Xu T; Zhang T; Qian W; Luo Y
J Pharm Pharmacol; 2012 Apr; 64(4):597-603. PubMed ID: 22420665
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
16. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kappaB signaling pathway.
Tong Q; Zheng L; Lin L; Li B; Wang D; Huang C; Li D
Respir Res; 2006 Mar; 7(1):37. PubMed ID: 16512910
[TBL] [Abstract][Full Text] [Related]
17. Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability.
Zhang J; Cao R; Zhang Y; Jia T; Cao Y; Wahlberg E
FASEB J; 2009 Jan; 23(1):153-63. PubMed ID: 18827023
[TBL] [Abstract][Full Text] [Related]
18. High glucose-induced upregulation of Rho/Rho-kinase via platelet-derived growth factor receptor-beta increases migration of aortic smooth muscle cells.
Akiyama N; Naruse K; Kobayashi Y; Nakamura N; Hamada Y; Nakashima E; Matsubara T; Oiso Y; Nakamura J
J Mol Cell Cardiol; 2008 Aug; 45(2):326-32. PubMed ID: 18561944
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2.
Park JS; Kim MH; Chang HJ; Kim KM; Kim SM; Shin BA; Ahn BW; Jung YD
Int J Oncol; 2006 Nov; 29(5):1247-52. PubMed ID: 17016658
[TBL] [Abstract][Full Text] [Related]
20. Apigenin inhibits cell migration through MAPK pathways in human bladder smooth muscle cells.
Liu Q; Chen X; Yang G; Min X; Deng M
Biocell; 2011 Dec; 35(3):71-9. PubMed ID: 22423483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
